[go: up one dir, main page]

AU2001244602A1 - Drugs retained in target tissue over long time - Google Patents

Drugs retained in target tissue over long time

Info

Publication number
AU2001244602A1
AU2001244602A1 AU2001244602A AU4460201A AU2001244602A1 AU 2001244602 A1 AU2001244602 A1 AU 2001244602A1 AU 2001244602 A AU2001244602 A AU 2001244602A AU 4460201 A AU4460201 A AU 4460201A AU 2001244602 A1 AU2001244602 A1 AU 2001244602A1
Authority
AU
Australia
Prior art keywords
long time
target tissue
over long
tissue over
drugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001244602A
Inventor
Eiko Hayashi
Haruya Sato
Hideyuki Shirae
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Publication of AU2001244602A1 publication Critical patent/AU2001244602A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001244602A 2000-03-30 2001-03-28 Drugs retained in target tissue over long time Abandoned AU2001244602A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-93775 2000-03-30
JP2000093775 2000-03-30
PCT/JP2001/002604 WO2001074399A1 (en) 2000-03-30 2001-03-28 Drugs retained in target tissue over long time

Publications (1)

Publication Number Publication Date
AU2001244602A1 true AU2001244602A1 (en) 2001-10-15

Family

ID=18608913

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001244602A Abandoned AU2001244602A1 (en) 2000-03-30 2001-03-28 Drugs retained in target tissue over long time

Country Status (4)

Country Link
US (1) US20030103934A1 (en)
EP (1) EP1279405A1 (en)
AU (1) AU2001244602A1 (en)
WO (1) WO2001074399A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000050059A1 (en) * 1999-02-24 2000-08-31 The Uab Research Foundation Taxane derivatives for targeted therapy of cancer
EP1292337A2 (en) 2000-06-08 2003-03-19 La Jolla Pharmaceutical Multivalent platform molecules comprising high molecular weight polyethylene oxide
UA78726C2 (en) 2001-11-01 2007-04-25 Sciclone Pharmaceuticals Inc Pharmaceutical composition of thymosin alpha 1 conjugated with polyethylene glycol, method for production, and method for treatment
US7708978B2 (en) 2002-05-14 2010-05-04 Beijing Jiankai Technology Co., Ltd. Targeted hydrophilic polymer, binders with interferon and medical composite comprising above binders
US6596757B1 (en) * 2002-05-14 2003-07-22 Immunogen Inc. Cytotoxic agents comprising polyethylene glycol-containing taxanes and their therapeutic use
CN103251647A (en) * 2004-05-27 2013-08-21 巴克斯特国际公司 Methods for treating bleeding disorders using sulfated polysaccharides
CN101175490B (en) * 2005-05-12 2011-06-08 尼普洛株式会社 Agent for improving circulatory disorder
EP1969031B1 (en) * 2005-12-05 2009-06-03 Nitto Denko Corporation Polyglutamate-amino acid conjugates and methods
WO2009105258A1 (en) * 2008-02-22 2009-08-27 Nektar Therapeutics Al, Corporation Oligomer conjugates of heteropentacyclic nucleosides
US20100316764A1 (en) * 2009-06-10 2010-12-16 Engrain, LLC Flour supplement compositions and methods for preparing wheat flour
SI2646470T1 (en) 2010-11-30 2017-05-31 F. Hoffmann-La Roche Ag Low affinity anti-transferrin receptor antibodies and their use to transfer therapeutic scfv across the blood brain barrier
CA3131967A1 (en) * 2010-12-29 2012-07-05 F. Hoffman-La Roche Ag Small molecule conjugates for intracellular delivery of nucleic acids
CN105504014B (en) * 2015-12-28 2018-11-20 中国人民解放军第三军医大学第一附属医院 The polyethylene glycol derivative of beta-lactamase inhibitory peptide and its application

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998013381A1 (en) * 1996-09-26 1998-04-02 Ajinomoto Co., Inc. Modified physiologically active proteins and medicinal compositions containing the same
KR19990029749A (en) * 1997-09-17 1999-04-26 미우라 아끼라 Divalent reactive water soluble polymer derivatives and composites containing them
WO2001002851A1 (en) * 1999-06-30 2001-01-11 Ajinomoto Co., Inc. Method for screening targeting dds preparation

Also Published As

Publication number Publication date
WO2001074399A1 (en) 2001-10-11
EP1279405A1 (en) 2003-01-29
US20030103934A1 (en) 2003-06-05

Similar Documents

Publication Publication Date Title
AU2002225912A1 (en) Tissue removal using biocompatible materials
AU2001281758A1 (en) Biocompatible materials
AU2001241963A1 (en) Improved medical procedure
AU2001269529A1 (en) Medicine comprising dicyanopyridine derivative
AU7862200A (en) Flip-wing tissue retainer
AU4198500A (en) Suture-passing forceps
AU2002246515A1 (en) Medicated tattoos
AU2001254786A1 (en) Medical implant
AU2001253342A1 (en) Surgical implant system
AU2001287023A1 (en) Plasma-derived-fibrin-based matrices and tissue
AU2001269508A1 (en) Drugs or cosmetics
AU2001259702A1 (en) Tissue regrafting
AU2002237706A1 (en) Bioactive surgical suture
AU2001247841A1 (en) Medical procedure
AU2001268525A1 (en) Human kinases
AU2001288612A1 (en) Human kinases
AU2001244602A1 (en) Drugs retained in target tissue over long time
AU2001277959A1 (en) Human kinases
AU2001238488A1 (en) Human kinases
AU1608201A (en) Human zven proteins
AU2001243515A1 (en) Combination drug therapy
WO2002018574A3 (en) Human interleukin-four induced protein
AU2002227925A1 (en) Human beta-defensin-3
AU2001232244A1 (en) Drug comprising combination
AU2001255573A1 (en) Human kinases